Future Outlook of the Overactive Bladder Treatment Market: Growth, Trends, and Emerging Opportunities Explored
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the overactive bladder treatment market grown in recent years?
The market size for the treatment of overactive bladder has experienced consistent growth over the past few years. The value of this market is projected to increase from $3.15 billion in 2024, to $3.25 billion in 2025 with a compound annual growth rate (CAGR) of 3.3%. Factors contributing towards this growth in the historic period include the evolution of medication, improved awareness amongst patients, demographic changes, clinical guidelines and investment into research.
How is the overactive bladder treatment market size expected to evolve during the forecast period?
It is anticipated that the overactive bladder treatment market will experience robust growth in the forthcoming years, with an estimated value of $3.99 billion in 2029, based on a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this growth during the forecast period include an aging population, developments in therapy, personalized medical treatment, investments in healthcare, and a focus on patient-oriented care. Key trends predicted during this forecast period comprise non-drug interventions, digital healthcare innovations, the acceptance of alternative medicine methods, gender-focused strategies, and comprehensive care.
Get your overactive bladder treatment market report here!
https://www.thebusinessresearchcompany.com/report/overactive-bladder-treatment-global-market-report
Which key drivers are propelling the overactive bladder treatment market’s growth?
The overactive bladder treatment market is poised for growth, fueled by an increase in the geriatric population. People aged 65 and up, often referred to as the geriatric population, are prone to urinary tract infections due to factors such as reduced urine flow, overactive bladder, kidney stones or prostate enlargement. Hence, the need for overactive bladder treatments increases. The ReliefWeb, an American humanitarian information source, reported in July 2022 that the global proportion of people aged 65 or older is anticipated to rise from 10% in 2022 to 16% by 2050. Additionally, this demography is projected to escalate to 94 million by 2050, representing 23% of the total population. Thus, the augmenting geriatric population is a major contributor to the expansion of the overactive bladder treatment market.
What are the market segments in the overactive bladder treatment industry?
The overactive bladder treatment market covered in this report is segmented –
1) By Diseases Type: Idiopathic Bladder Overactivity, Neurogenic Bladder Overactivity
2) By Therapy: Anticholinergics, Mirabegron, Neurostimulation, Intravesical Instillation, Other Therapies
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
Subsegments:
1) By Idiopathic Bladder Overactivity: Urge Incontinence, Urgency Frequency
2) By Neurogenic Bladder Overactivity: Spinal Cord Injury-Related Overactivity, Multiple Sclerosis-Related Overactivity, Stroke-Related Overactivity
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9950&type=smp
Which leading companies are shaping the growth of the overactive bladder treatment market?
Major companies operating in the overactive bladder treatment market include AbbVie Inc., Astellas Pharma Inc., Laborie Medical Technologies Corporation, Endo International plc, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson Services Inc., Medtronic plc, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Limited, Cogentix Medical Inc., Dr. Reddy’s Laboratories Ltd., Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Limited, Merck & Co. Inc., Macleods Pharmaceuticals Ltd., Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Company, GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Novartis International AG, Daiichi Sankyo Company ltd., Boston Scientific Corporation, Grünenthal GmbH, Collegium Pharmaceutical Inc.
What key trends are currently impacting the overactive bladder treatment market’s development?
One prevalent trend in the overactive bladder treatment market is the approval of new products. Leading firms in the market are innovating and integrating their products with state-of-the-art technologies to maintain their space in the market. To illustrate, Avation Medical Inc., a U.S. company specializing in advanced neuromodulation & digital health, received FDA approval in April 2023 for The Vivally System. This innovative system, comprising of a wearable, non-invasive bladder control therapy device and an accompanying mobile app, is designed to alleviate symptoms of urge urinary incontinence and urine urgency, common in patients with overactive bladder syndrome. The system merges a comfortable, wearable garment for the ankle, with a smart controller that supplies personalized neuromodulation energy to the tibial nerve.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9950
Which geographic areas are influencing the growth of the overactive bladder treatment market?
North America was the largest region in the overactive bladder treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the overactive bladder treatment market report during the forecast period. The regions covered in the overactive bladder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Medical Equipment Maintenance Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/medical-equipment-maintenance-global-market-report
Dialysis Devices And Equipment Global Market Report 2024
Gastrointestinal Bleeding Treatment Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
